Impact of low‐dose involved‐field radiation therapy on pediatric patients with lymphocyte‐predominant Hodgkin lymphoma treated with chemotherapy: A report from the Children's Oncology Group

Treatment of pediatric lymphocyte‐predominant Hodgkin lymphoma (LPHL) is controversial but has typically consisted of both chemotherapy and radiation. Radiation therapy is associated with potential late effects in children and adolescents. We examined the impact of radiation therapy on long‐term outcome of patients with LPHL treated on CCG‐5942, a large pediatric cooperative group study of Hodgkin lymphoma (HL).

[1]  D. Hasenclever,et al.  Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report. , 2012, European journal of cancer.

[2]  R. Gascoyne,et al.  Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome. , 2011, Blood.

[3]  P. Borchmann,et al.  Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group. , 2011, Blood.

[4]  G. Pruneri,et al.  Rituximab in Hodgkin lymphoma: is the target always a hit? , 2011, Cancer treatment reviews.

[5]  S. Lipshultz,et al.  Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer , 2011, Pediatric Cardiology.

[6]  A. Horwich,et al.  Lymphocyte-predominant Hodgkin lymphoma--clinical features and treatment outcomes from a 30-year experience. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Bourhis,et al.  Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  A. Whittemore,et al.  Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. Gascoyne,et al.  Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  B. Coiffier,et al.  Nodular, lymphocyte‐predominant Hodgkin lymphoma , 2010, Cancer.

[11]  D. Green,et al.  Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  V. Diehl,et al.  Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  A. Ng,et al.  Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. , 2008, International journal of radiation oncology, biology, physics.

[14]  R. Müller,et al.  Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. R. Pinkerton,et al.  Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma – a Children's Cancer and Leukaemia Group report , 2007, British journal of haematology.

[16]  D. Hasenclever,et al.  Resection alone in 58 children with limited stage, lymphocyte‐predominant Hodgkin lymphoma–experience from the European network group on pediatric Hodgkin lymphoma , 2007, Cancer.

[17]  P. Mauch,et al.  Nodular lymphocyte-predominant hodgkin lymphoma. , 2007, Seminars in radiation oncology.

[18]  P. Hall,et al.  Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Hancock,et al.  Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  R. Pieters,et al.  High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only , 2006, Leukemia & lymphoma.

[21]  M. Barton,et al.  Long‐term outcome after radiotherapy alone for lymphocyte‐predominant Hodgkin lymphoma , 2005, Cancer.

[22]  W. Hobbie,et al.  Fertility in males treated for Hodgkins disease with COPP/ABV hybrid , 2005, Pediatric blood & cancer.

[23]  S. Lipsitz,et al.  Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  W. Chan,et al.  Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma: a Report of 21 Cases from the Nebraska Lymphoma Study Group , 2004, Leukemia & lymphoma.

[25]  L. Robison,et al.  High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  H. Katzenstein,et al.  Results of Little or No Treatment for Lymphocyte-Predominant Hodgkin Disease in Children and Adolescents , 2003, Journal of pediatric hematology/oncology.

[27]  G. Leverger,et al.  Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric Oncology. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  P. Davis,et al.  Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  J. Friedberg,et al.  Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. , 2002, Blood.

[30]  J. Cox,et al.  Radiotherapy Alone for Lymphocyte‐Predominant Hodgkin's Disease , 2002, Cancer journal.

[31]  M. Hudson,et al.  Lymphocyte-Predominant Hodgkin Disease in Children , 2002, Journal of pediatric hematology/oncology.

[32]  V. Diehl,et al.  European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. , 2000, Blood.

[33]  T. Lister,et al.  Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  R. Pötter,et al.  High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  V. Diehl,et al.  Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  K. Lamborn,et al.  Second cancers following pediatric Hodgkin's disease. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  F. Behm,et al.  Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experience. , 1997, Medical and pediatric oncology.

[38]  G. Pinkus,et al.  Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  W. Chan,et al.  Clonality in nodular lymphocyte-predominant Hodgkin's disease. , 1997, The New England journal of medicine.

[41]  S. Pileri,et al.  Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. , 1997, The New England journal of medicine.

[42]  R. Alsabeh,et al.  Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method. , 1997, American journal of clinical pathology.

[43]  M. Paulli,et al.  Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. , 1997, Leukemia & lymphoma.

[44]  L. Robison,et al.  Breast cancer and other second neoplasms after childhood Hodgkin's disease. , 1996, The New England journal of medicine.

[45]  K. Franssila,et al.  Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non‐Hodgkin's lymphomas , 1983, Cancer.

[46]  R. Lukes,et al.  The pathology and nomenclature of Hodgkin's disease. , 1966, Cancer research.

[47]  Ronald C. Chen,et al.  Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  L. Constine,et al.  Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other. , 2010, Seminars in radiation oncology.

[49]  G. Canellos,et al.  What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma? , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  R. Arceci.  Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease , 2008 .

[51]  K. Lennert,et al.  Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular) , 2004, Journal of Cancer Research and Clinical Oncology.